New INVEST Drug Abuse Research Fellow Sujung Yoon, M.D., Ph.D., South Korea, will spend 12 months under the mentorship of Perry F. Renshaw, F.M.D., Ph.D., M.B.A., The Brain Institute, University of Utah, to focus on the application of multinuclear magnetic resonance spectroscopy markers of brain health in response to treatment.
Dr. Yoon and Dr. Renshaw have already been working together evaluating the effects of citicoline and, based on their findings in methamphetamine-dependent adolescents, plan in the next year to assess the effects of citicoline as a cognitive enhancer for patients with methamphetamine dependence. Dr. Yoon will focus specifically on the application of multinuclear magnetic resonance spectroscopy markers of brain health in response to treatment.
Get this Publication
Get Email Updates
2015 NIDA International Forum
June 12 – 15, 2015